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Abstract
Daptomycin is an extensively used anti-staphylococcal agent due to the rise in methicillin-resistant Staphylococcus aureus,
but the mechanism(s) of resistance is poorly understood. Comparative genome sequencing, transcriptomics, ultrastructure,
and cell envelope studies were carried out on two relatively higher level (4 and 8 mg/ml21) laboratory-derived daptomycin-
resistant strains (strains CB1541 and CB1540 respectively) compared to their parent strain (CB1118; MW2). Several mutations
were found in the strains. Both strains had the same mutations in the two-component system genes walK and agrA. In strain
CB1540 mutations were also detected in the ribose phosphate pyrophosphokinase (prs) and polyribonucleotide
nucleotidyltransferase genes (pnpA), a hypothetical protein gene, and in an intergenic region. In strain CB1541 there
were mutations in clpP, an ATP-dependent protease, and two different hypothetical protein genes. The strain CB1540
transcriptome was characterized by upregulation of cap (capsule) operon genes, genes involved in the accumulation of the
compatible solute glycine betaine, ure genes of the urease operon, and mscL encoding a mechanosensitive chanel.
Downregulated genes included smpB, femAB and femH involved in the formation of the pentaglycine interpeptide bridge,
genes involved in protein synthesis and fermentation, and spa encoding protein A. Genes altered in their expression
common to both transcriptomes included some involved in glycine betaine accumulation, mscL, ure genes, femH, spa and
smpB. However, the CB1541 transcriptome was further characterized by upregulation of various heat shock chaperone and
protease genes, consistent with a mutation in clpP, and lytM and sceD. Both strains showed slow growth, and strongly
decreased autolytic activity that appeared to be mainly due to decreased autolysin production. In contrast to previous
common findings, we did not find any mutations in phospholipid biosynthesis genes, and it appears there are multiple
pathways to and factors in daptomycin resistance.
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Introduction
Increases in the number of methicillin-resistant Staphylococcus
aureus (MRSA) strains, increases in vancomycin minimum inhib-
itory concentrations (MICs) in such strains resulting in vancomy-
cin-intermediate S. aureus (VISA) and vancomycin-resistant S.
aureus (VRSA), have provided impetus to the development of novel
antistaphylococcal antimicrobial agents [1]. Daptomycin is an
acidic lipodepsipeptide natural product with high activity against
gram-positive bacteria [2]. It has been approved for the treatment
of complicated skin and soft tissue infection, S. aureus bacteremia
and S. aureus right-sided endocarditis in the US [3]. Daptomycin is
a significant component of the anti-staphylococcal armamentar-
ium and is an extensively used therapeutic agent.
The antibacterial activity of daptomycin is dependent on
calcium [4], and the agent is believed to interact with the
membrane via its lipophilic tail. Daptomycin has been shown to
cause membrane depolarization and leakage of intracellular
metabolites and ions [5,6]. Daptomycin has been proposed to
oligomerize on the membrane and disrupt its functional integrity,
or to insert into the membrane and cause positive membrane
curvature [6–9]. Transcriptional profiling studies of the response
to daptomycin have shown induction of the cell wall stress
stimulon including its critical two-component regulator vraSR in S.
aureus and liaSR in Bacillus subtilis, and genes responsive to
membrane depolarization [10,11]. Recent work by Pogliano et
al. [12] has shown that insertion of daptomycin into the
membrane results in the formation of membrane patches that
redirect the localization of proteins involved in cell division and
cell wall synthesis, thereby allowing reconciliation of previous
observations on the mode of action of daptomycin involving both
membrane depolarization and inhibition of cell wall synthesis.
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Given the extensive use of daptomycin in treatment of infectious
diseases it is important to understand mechanisms of resistance
against the agent. It has proved possible to select strains showing
decreased daptomycin susceptibility/daptomycin resistance in
vitro by cultivation in increasing concentrations of the agent
[13]. Also, daptomycin-resistant strains have been isolated from
patients undergoing daptomycin therapy [14–17]. Furthermore,
VISA may show decreased susceptibility to daptomycin [18–21].
The mechanism of daptomycin resistance has been studied and
various observations have been made, but there is no one
consensus mechanism of daptomycin resistance. Changes in
membrane potential or the ability of daptomycin to depolarize
the membrane have been observed in resistant strains [13,22–24].
Various changes in the cytoplasmic membrane in daptomycin-
resistant strains have been described. Jones et al. [22] reported on
a clinical daptomycin resistant strain and found it had increased
membrane fluidity, increased translocation of lysyl-phosphatidyl
glycerol to the outer half of the cytoplasmic membrane bilayer,
and the cells had an increased positive charge compared to a
susceptible parent strain. Mishra et al. [25] reported on
laboratory-derived daptomycin resistant strains and they found
increased lysyl-phosphatidyl glycerol and increased flipping of this
phospholipid to the outer half of the bilayer, increased expression
of mprF, a gene encoding an enzyme responsible for adding lysine
to phosphatidyl glycerol forming the positively charged species
lysylphosphatidyl glycerol [26,27]. Also the dlt operon, which is
responsible for adding D-alanine residues to teichoic acid thereby
reducing its negative charge, was increased in expression.
However, in contrast to the findings of Jones et al. [22] membrane
fluidity was decreased, and despite increased mprF and dlt operon
expression, cell positive charge was not increased in the report of
Mishra et al. [25]. Nevertheless, in a later paper [28] studying a
new day 20 serial in vitro passage daptomycin resistant strain small
changes in lysylphosphatidyl glycerol features, increased caroten-
oid concentrations, decreased membrane fluidity and different
mutations were observed compared to previous day 20 isolates
[25]. However, Mishra et al. [29] have reported increased
membrane fluidity in isogenic pairs of clinical MRSA daptomy-
cin-resistant strains that were also cross-resistant to host defense
cationic antimicrobial peptides.
Comparative genome sequencing of laboratory-derived dapto-
mycin-resistant strains [30] revealed mutations in mprF, rpoB (RNA
polymerase subunit B), and walK, the sensor component of a two-
component system playing a critical role in S. aureus cell wall
metabolism [31]. Daptomycin susceptibility is increased in mprF
knockout strains, and when mprF expression is decreased using an
mprF antisense plasmid [32]. In those daptomycin-resistant strains
where mutations in mprF have been detected it is believed they are
gain of function mutations [32]. However mprF mutations are not
found in all daptomycin-resistant strains [15,33].
Cui et al. [34] carried out whole genome sequencing of a
laboratory-derived daptomycin resistant strain 10*3d1 previously
described by Camargo et al. [35]. Five mutations were found, one
in a hypothetical protein gene, mutations in genes rplV, rplC
encoding ribosomal proteins, and a mutation in rpoB. Replacement
of intact rpoB in the parent strain with mutated rpoB conferred the
phenotype of reduced daptomycin susceptibility, the MIC going
from 0.25 to 1.5 mg ml21. However, mutations in rpoB have not
been found in all strains studied. In order to attain relatively high
daptomycin MICs strains typically have mutations in more than
one gene, and mutations are not found in the same genes in all
strains [15,18,30,33].
In this paper we report on genomic, transcriptomic, ultrastruc-
ture, and cell wall autolysis studies of two strains, CB1540 and
CB1541, with relatively high daptomycin MICs (CB1541
4 mg ml21and CB1540 8 mg ml21), derived from methicillin-
resistant parent strain MW2 (CB1118) by serial passage. Neither
of the strains have mutations in mprF or rpoB, but both are mutated
in walK and agrA, and other genes. The transcriptomes of the
strains showed some common features and some differences. Both
strains showed significantly decreased autolytic activity.
Results and Discussion
Initial Characterization of The Strains
The daptomycin MIC for strains CB1540 and CB1541 were
8 mg ml21, and 4 mg ml21 respectively compared to 1 mg ml21 for
parent strain CB1118 (Table 1). The MIC for vancomycin was
increased from 0.5 mg ml21 to 2 mg ml21 in strains CB1540 and
CB1541. However, the nafcillin MIC was decreased from
16 mg ml21 in the parent to 4 mg ml21 in the two daptomycin-
resistant strains. Sensitization of daptomycin resistant strains to b-
lactam antibiotics has been referred to as the ‘‘seesaw effect’’ [36]
and has been observed in heterogeneous but not homogenous
MRSA strains [37]. The underlying mechanism of the see saw
effect is unclear. On agar plates, the colonies of CB1540 and
CB1541 were white in color (Table 1), indicating a lower
carotenoid content, and significantly smaller than those of
CB1118. In liquid culture the strains grew much slower than the
parent strain with mean generation times of 47 min and 62 min
for strains 1540 and 1541 respectively compared to 29 min for
CB1118 (Table 1). Slow growth is often associated with decreased
antibiotic susceptibility [38] including in VISA [39].
Mutations in strains CB1540 and CB1541 compared to
CB1118
These mutations present in the strain are summarized in
Table 2.
walk. A change from a C to T at position 28 resulting in an
amino acid change from leucine to phenylalanine was found in
walK in both strains. This is not the same mutation as that reported
by Friedman et al. [30]. Amino acid substitutions were not
detected in any functional domains. WalK is the histidine kinase
sensor of an essential two-component system that controls
peptidoglycan metabolism through regulation of the expression
of most of the peptidoglycan hydrolase genes [31].
agrA. There was a change from a C to A at position 300
resulting in an amino acid change from tyrosine to a nonsense
mutation in agrA in both strains resulting in a prematurely
terminated protein.
The agr locus in S. aureus encodes a quorum sensing system that
controls the expression of virulence and other genes via a two-
component system [40,41]. AgrA is a response regulator that
upregulates its own promoter, P2, in the agr locus, and the RNAIII
promoter. RNAIII is the effector of the agr system. Several
hundred genes have been identified to be upregulated by RNAIII
[42]. Tsuji et al. [43] have noted an association with an increase in
the vancomycin-intermediate phenotype in agr-defective strains.
Also, agr mutants show decreased autolysis [20,44].
pnpA. There was a mutation in position 1037 changing a T to
a C and a leucine to proline in strain CB1540. Polynucleotide
phosphorylase is a phosphorolytic exoribonuclease. In gram-
negative enteric bacteria it has been shown that PnpA controls the
expression of small non-coding RNAs. PnpA is involved in quality
control of RNA precursors and plays roles in expression of
virulence functions and growth resumption after cold shock [45–
48]. There were extensive changes in transcription in strain 1540
and PnpA may be involved in these.
S. aureus Daptomycin Resistance
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prs. A C was changed to a T in position 346 resulting in a
change from an alanine to valine in strain CB1540. This gene
encodes phosphoribosylpyrophosphate synthetase and a mutation
in this gene may cause requirements for purine and pyrimidine
nucleotides, consistent with the critical role of ribosyl pyrophos-
phate in the biosynthesis of these molecules. There was significant
down-regulation of the purine biosynthetic operon in strain
CB1540, perhaps reflecting increased reliance on exogenous
purines.
clpP. There was a mutation in the gene encoding ClpP
protease in strain CB1541 at position 94 from a G to an A
changing a glycine to aspartic acid. clpP is involved in protein
quality control degrading abnormal proteins accumulating in
stress conditions. Michel et al. [49] have shown that ClpP in S.
aureus has a global regulatory impact on various regulons including
the heat shock response, oxidative stress response, autolysis and
DNA repair. Study of a DclpP mutant showed decreased
expression of agr and agr-dependent virulence factors, and
increased expression of heat shock regulon genes controlled by
CtsR and HrcA. The transcriptional profile of strain CB1541 is
characterized by significant upregulation of genes encoding
chaperones and proteases. However, McGillvray et al. [50] have
recently described chemical inhibition of S. aureus ClpXP by a
pharmacological inhibitor, F2. F2 treatment sensitized S. aureus to
cell envelope-active antibiotics including daptomycin. Including
strains show decreased susceptibility to daptomycin.
In addition there were mutations in one gene for a hypothetical
protein in CB1540 and two hypothetical protein genes in strain
CB1541 (Table 2).
Mutations Identified in Other Studies of Daptomycin-
Resistant Strains
A variety of mutations have been detected in daptomycin-
resistant strains. In the first study of this Friedman et al. [30] using
complete-genome comparisons (CGS) on various laboratory-
derived strains detected mutations resulting in amino acid
substitutions in MprF, sensor kinase WalK, and the b and b9
chains of RNA polymerase RpoB and RpoC. In addition
intergenic mutations were detected. However, Pillai et al. [33]
detected no amino acid substitutions in MprF in clinical S. aureus
isolates that developed vancomycin heteroresistance and dapto-
mycin nonsusceptibility. Cui et al. [34] have shown that
introduction of a mutation in rpoB into a vancomycin-susceptible
S. aureus VSSA conferred resistance to both vancomycin and
daptomycin on the resulting strain.
Recently, Peleg et al., [51] have reported the results of whole
genome sequencing on 21 clinical and 12 laboratory strains that
developed daptomycin-nonsusceptibility after exposure to dapto-
mycin compared to their daptomycin susceptible parent strains.
The MICs of the nonsusceptible strains were 2 or 4 ug
daptomycin ml21. The laboratory strains had an average of two
mutations in coding regions compared to six in clinical strains. We
found six mutations in our laboratory-derived strains, which had
higher daptomycin MICs than those studied by Peleg et al. [51].
One hundred percent of the strains studied by Peleg et al. [51] had
mutations in phospholipid biosynthesis genes, including mutations
in the previously identified mprF and other phospholipid biosyn-
thesis genes that were not found in our strains. Mehta et al. [52]
recently reported various point mutations in mprF in a group of
clinical MRSA strains. Varying percentages of the strains studied
by Peleg et al. [51] had mutations in genes in other gene categories
including cellular processes, transporters, protein synthesis, regu-
latory functions and two-component systems. As in our study,
Peleg et al. [51] noted mutations in walK and agrA in some strains,
and in clpX in some strains whereas we noted a mutation clpP in
strain CB1541. It is possible that mutations in various genes may
result in slow growth in daptomycin-resistant mutants.
Mutations Identified in VISA Strains
As pointed out above VISA may show decreased daptomycin
susceptibility [18–21]. Strains CB1540 and CB1541, which were
selected for decreased daptomycin susceptibility, also show
decreased vancomycin susceptibility. Hence, it is likely of interest
to see what mutations have been reported in VISA strains. This
information has been reviewed by Howden et al. [53]. Mutations
in genes in the same gene systems noted in our strains include a
frameshift mutation in agrC, a premature stop codon in yycH, and a
frameshift mutation in prsA [54]. Other mutations not detected in
strains CB1540 and CB1541 by us have been described in various
VISA strains [53].
Recently, Shoji et al. [39] observed an association in mutations
in walKR, clpP, graRS, and vraSR in VISA strains, with mutations in
walKR being carried most frequently. Separate introduction of
mutated walK or clpP into a VISA parent strain raised the
vancomycin MIC from 1 to 2 mg ml21, but introduction of both
raised the MIC to 4 mg ml21, and resulted in a thickened cell wall
and decreased autolysis. Howden et al. [55] have emphasized the
importance of mutations in walKR in the evolution of multidrug
resistance in S. aureus. Single mutation in either walK or walR led to
vancomycin and daptomycin co-resistance and cell wall thicken-
ing, which is typical of VISA. Similar functional studies would be
necessary to prove that the mutation in walK we observed
impacted daptomycin and vancomycin resistance.
The Strain CB1540 Transcriptome
Compared to strain CB1118, 170 genes were increased in
expression and 152 genes were decreased in expression two fold or
more in strain CB1540 (Table S1). Considerable numbers of genes
in the categories of cell envelope (although most were genes of the
cap operon), cellular processes, metabolism, regulatory function,
hypothetical proteins and proteins of unknown function were
upregulated.
Table 1. Strains studied and antibiotic MICs.
Strain Antibiotic MIC (ug ml
21)
Mean generation time
(min)
%OD465 warm
methanol extract
Daptomycin Vancomycin Nafcillin
CB1118 (MW2) 1 0.5 16 29 100
CB1540 8 2 4 47 54.4
CB1541 4 2 4 62 52.5
doi:10.1371/journal.pone.0058469.t001
S. aureus Daptomycin Resistance
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Various genes of the cap operon were strongly upregulated. The
cap genes encode a microcapsule associated with virulence [56].
Over expression of cap genes has been shown in VISA isolates
compared to their VSSA parent strains [18,57,58]. It seems
possible that production of capsular polysaccharide material could
impede the access of daptomycin to its target in the cytoplasmic
membrane. However, the cap operon was not upregulated in strain
CB1541.
In strain CB1540, several genes involved in the likely
accumulation of the compatible solute glycine betaine were
upregulated including cudT (SAV2615), a likely choline transport-
er, betA (SAV2612, choline dehydrogenase), and gbsA (SAV2613,
glycine betaine aldehyde dehydrogenase). These genes are
involved in the uptake and metabolism of choline to produce
glycine betaine [59]. Also opuD2, glycine betaine transporter 2,
SAV 2185, a glycine betaine transporter opuD homolog, and proP,
a putative proline/betaine transporter were upregulated. S. aureus
accumulates proline and glycine betaine in response to osmotic
stress [60]. However, glycine betaine also has beneficial effects on
protein structure in stressed cells [61,62], and accumulation of
glycine betaine may allow bacteria to be primed to withstand the
stress of daptomycin challenge. Cell wall and membrane active
antibiotics cause oxidative stress and protein aggregation and
misfolding as revealed by the induction of molecular chaperones
[63–65].
Genes encoding the surface proteins SdrD, ClfA and ClfB were
upregulated. These proteins play a role in the ability of S. aureus to
adhere to squamous epithelial cells [66].
Urease operon genes (ure) were upregulated. Ammonia and CO2
are produced through urease activity and ammonia production
may serve to neutralize environmental acidity. Alternatively,
urease induction may be necessary to detoxify excess urea that
may be produced through possible changes in metabolism in the
mutant.
mscL was upregulated 2.1 fold. This gene encodes a large
conductance mechanosensitive channel that can relieve excess
turgor pressure building up in bacterial cells [67]. Perhaps the
upregulation of various genes involved in osmoregulation leads to
higher levels of compatible solutes in the mutants and MscL
relieves this turgor pressure that develops as needed. This gene was
also upregulated in strain CB1541 (Table S2).
Genes encoding enzymes of the nitrate and nitrite reductase
complexes (narH, narE and narI) that are increased in expression
under anaerobic conditions were upregulated in strain CB1540.
Various transcriptional regulators were upregulated including
gntR, a gluconate operon repressor; sarH2, staphylococcal acces-
sory regulator U; icaR, the ica operon repressor; and nirR,
transcriptional regulator of the nir operon.
Several genes encoding hypothetical proteins were strongly
upregulated including SAV1509, 7.8 fold, MW2624, 9 fold;
MW2454, 5.9 fold; MW0920, 5.2 fold; MW0523, 4.3 fold;
SAV2205, 5.6 fold.
A significant number of genes were down regulated in
expression in strain CB1540 in the categories of cell envelope,
energy metabolism, protein synthesis, purines-pyrimidines nucle-
osides and nucleotides, transport and binding proteins, and
hypothetical proteins.
SAV2515, encoding probable transmembrane protein SmpB,
was down regulated 11.2 fold. smpB encodes the small protein B
that binds to transfer-messenger RNA (tmRNA). It plays essential
roles in rescuing the tmRNA molecule from degradation in the
cell, enhancing the aminoacylation of tmRNA and mediating the
binding of tmRNA to the ribosome [68]. It is also reported that
tmRNA is required for the growth of Bacillus subtilis under stress
T
a
b
le
2
.
Si
n
g
le
n
u
cl
e
o
ti
d
e
p
o
ly
m
o
rp
h
is
m
s
in
st
ra
in
s
C
B
1
5
4
0
an
d
C
B
1
5
4
1
co
m
p
ar
e
d
to
p
ar
e
n
t
st
ra
in
C
B
1
1
1
8
.
S
tr
a
in
L
o
cu
s
ID
G
e
n
e
N
a
m
e
P
ro
d
u
ct
S
ta
rt
E
n
d
M
u
ta
ti
o
n
p
o
si
ti
o
n
N
u
cl
e
o
ti
d
e
ch
a
n
g
e
A
m
in
o
a
ci
d
ch
a
n
g
e
M
u
ta
ti
o
n
p
o
si
ti
o
n
in
p
ro
te
in
C
B
1
5
4
0
M
W
0
0
1
9
w
a
lK
tw
o
-c
o
m
p
o
n
e
n
t
se
n
so
r
h
is
ti
d
in
e
ki
n
as
e
1
1
8
2
7
2
8
C
R
T
LR
F
9
M
W
0
4
5
5
p
rs
ri
b
o
se
-p
h
o
sp
h
at
e
p
yr
o
p
h
o
sp
h
o
ki
n
as
e
1
9
6
6
7
0
1
C
R
T
A
R
V
2
3
4
M
W
1
1
0
9
co
n
se
rv
e
d
h
yp
o
te
h
ti
ca
l
p
ro
te
in
1
1
6
4
7
3
9
8
T
R
A
LR
H
1
3
3
M
W
1
1
5
7
p
n
p
A
p
o
ly
ri
b
o
n
u
cl
e
o
ti
d
e
n
u
cl
e
o
ti
d
yl
tr
an
sf
e
ra
se
1
2
0
9
7
1
0
3
7
T
R
C
LR
P
3
4
6
M
W
1
9
6
3
a
g
rA
ac
ce
ss
o
ry
g
e
n
e
re
g
u
la
to
r
A
1
7
1
7
3
0
0
C
R
A
Y
R
*
1
0
0
C
B
1
5
4
1
M
W
0
0
1
9
w
a
lK
tw
o
-c
o
m
p
o
n
e
n
t
se
n
so
r
h
is
ti
d
in
e
ki
n
as
e
1
1
8
2
7
2
8
C
R
T
LR
F
9
M
W
0
7
3
0
cl
p
P
A
T
P
-d
e
p
e
n
d
e
n
t
C
lp
p
ro
te
as
e
p
ro
te
o
ly
ti
cs
u
b
u
n
it
h
o
m
o
lo
g
u
e
1
5
8
8
2
8
1
G
R
A
G
R
D
9
4
M
W
1
9
1
3
h
yp
o
th
e
ti
ca
l
p
ro
te
in
1
2
0
4
2
7
T
R
A
V
R
V
9
M
W
1
9
2
7
h
yp
o
th
e
ti
ca
l
p
ro
te
in
1
1
6
2
1
8
T
R
G
K
R
N
6
M
W
1
9
6
3
a
g
rA
ac
ce
ss
o
ry
g
e
n
e
re
g
u
la
to
r
A
1
7
1
7
3
0
0
C
R
A
Y
R
*
1
0
0
d
o
i:1
0
.1
3
7
1
/j
o
u
rn
al
.p
o
n
e
.0
0
5
8
4
6
9
.t
0
0
2
S. aureus Daptomycin Resistance
PLOS ONE | www.plosone.org 4 March 2013 | Volume 8 | Issue 3 | e58469
[69]. The binding of SmpB to tmRNA is a critical component of
trans-translation where incompletely synthesized proteins receive a
peptide tag, an important aspect of quality control in protein
synthesis. In the absence of SmpB peptide tagging is abolished
[70]. The regulatory activities of certain repressor proteins are
increased in tmRNA (ssrA)-defective cells and SmpB mutants
mimic SsrA mutants. Decreased transcription of smpB may
decrease cellular levels of SmpB and lead to altered regulation
of gene expression.
Various genes involved in fermentation were downregulated
including genes encoding lactate dehydrogenase (lctE and SAV
2602), pflA encoding pyruvate formate-lyase activation enzyme,
and pflB, formate lyase.
Twenty three genes encoding proteins involved in protein
synthesis were down regulated, including a considerable number
of genes encoding ribosomal proteins. This is consistent with the
slow growth of this strain.
Genes of both the purine and pyrimidine biosynthesis operons
were significantly down regulated. Interestingly, strain CB1540
has a mutation is prs, phosphoribosyl synthetase. Perhaps this
causes the strain to depend more on exogenous purines and
pyrimidines.
spa, which encodes protein A (or precursor), was downregulated
3.7 fold. SAV0631 encoding a lipoprotein was down regulated 12
fold.
The Strain CB1541 Transcriptome
In strain CB1541 242 genes were over-expressed and 222 genes
were under-expressed 2 fold or more compared to strain CB1118
(Table S2). Significant number of genes in the categories of cellular
processes, central intermediary metabolism, energy metabolism,
protein fate, regulatory functions, transport and binding proteins
and hypothetical proteins were changed in expression (Table S2).
The strain CB1540 and CB1541 transcriptomes had changes in
expression of some genes in common but many differences were
apparent.
lytM encoding glycyl glycine endopeptidase, a peptidoglycan
hydrolase acting in the S. aureus interpeptide bridge, was
upregulated 8 fold. ssaA was upregulated 9.3 fold. ssaA is a
member of the walK regulon, as is lytM. Genes involved in
undecaprenyl phosphate metabolism were upregulated (SAV0683
and bacA).
Like CB1540, betA, and gbsA, involved in the conversion of
choline to glycine betaine were strongly upregulated. opuCC
encoding a glycine betaine/carnitine/choline ABC transporter
was upregulated, as was treP encoding a trehalose-specific PTS
transporter. The possible accumulation of compatible solutes
appears to be a component of daptomycin resistance in this strain
also. mscL encoding a large-conductance mechanosensitive chan-
nel was upregulated as it was in strain CB1540.
There was stronger upregulation of ureB-F in strain CB1541
than in CB1540.
In contrast to strain CB1540 genes involved in glycolysis and
fermentation tended to be upregulated.
Also, in contrast to strain CB1540, various stress protein genes
were upregulated including clpC, clpP, grpE, groES, clpX, groEL,
dnaJ, and msrA. These proteins are involved in correcting protein
misfolding, and degrading terminally damaged protein. This is
consistent with the mutation in clpP in that ClpP controls the
expression of stress protein chaperone and protease genes, as
revealed by their overexpression in a DclpP mutant [49].
SAV2095 encoding a protein similar to the sceD precursor was
upregulated 16.9 fold. sceD encodes a putative lytic transglycosy-
lases and inactivation of sceD resulted in impaired cell separation
[71].
SACOL2139 and MW0934 encoding hypothetical proteins
were upregulated 7.9 and 5 fold and, SAV0523 was overexpressed
6.1 fold.
Significant numbers of genes in the following categories were
down regulated: cellular process, energy metabolism, regulatory
functions, transport and binding proteins, and hypothetical
proteins. spa was downregulated 10.2 fold, and SAV0631
lipoprotein 7.9 fold. MW1888 was downregulated 22.1 fold,
MW2405 6.5 fold, MW2524 5.6 fold. Probable transmembrane
protein smpB was highly downregulated (15.7 fold) in CB1541 as it
was in strain CB1540.
The FemAB protein genes involved in peptidoglycan interpep-
tide bridge formation were downregulated. These genes were also
down regulated in strain CB1540. Strain CB1540 also showed
decreased autolysis and also may have a shortened interpeptide
brige.
Other cell wall genes down regulated were antiholin protein
gene lrgB and autolysin gene atl. lrgB is over expressed in response
to daptomycin [11]. Mehta et al. [52] also observed lrgB was
downregulated in the strains they studied. Downregulation of lrgB
expression may be a way of decreasing responsiveness to
daptomycin challenge.
crtN encoding squalene synthase involved in carotenoid biosyn-
thesis was down regulated two fold consistent with the lower
carotenoid content of strain CB1541.
Six genes from CB1540 and eight genes from CB1541 are
randomly selected and their expressions are confirmed by RT-
PCR (Table S4).
Transcriptional Profiling Studies in Other Daptomycin-
Resistant Strains And VISA
The first genome-wide transcriptional profiling study of a
daptomycin-resistant strain versus a susceptible parent appears to
be that of Camargo et al. [35]. These authors studied a laboratory-
derived strain (MIC 3 mg ml21). There was only limited similarity
between their results and ours. However, as in our results, opuD
and mscL were over-expressed.
Fischer et al [72] have reported both transcriptomic and
proteomic studies of a clinical daptomycin-resistant (MIC
2 mg ml21) and its susceptible parent strain. There was little
similarity in the transcriptome of this strain compared to our data.
There was significant upregulation of various lac genes, lytN, lytH,
cell wall biosynthesis genes and virulence factor genes in the Fisher
et al [72] study.
Mehta et al. [52] reported that vraS and vraR were over
expressed in three pairs of daptomycin-resistant strains versus their
susceptible parent strains. VraSR is the two-component system
that controls a significant part of the cell wall stress stimulon [73].
We did not observe over expression of vraS and vraR in our strains.
Transcriptional profiling studies of VISA strains compared to
VSSA parent strains have been reviewed by Howden et al. [53].
Overall, a variety of different transcriptomes have been observed
in different VISA strains in different studies. Upregulation of vraSR
and the cell wall stress stimulon, purine biosynthesis, graSR and
genes controlled by this two-component system and various
regulatory genes have been reported in some but not all strains.
The most consistent transcriptional change noted is down-
regulated expression of spa encoding protein A. spa transcription
was decreased in strains 1540 and 1541 (Tables S1 and S2).
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Decreased Autolysis of Strains CB1540 and CB1541
The Triton X-100 stimulated rates of autolysis of the parent and
mutant strain are shown in Figure 1a. Both daptomycin-resistant
strains showed markedly slower rates of autolysis than the parent
strain. This is a common but not universal finding in VISA and
daptomycin-resistant strains [15,18,36,53,74,75]. This decreased
rate of autolysis was also seen in crude cell walls retaining autolytic
activity of strains CB1540 and CB1541 compared to those isolated
from the parent strain that showed good activity (Figure 1b). This
indicates that either the enzyme(s) autolysin, or the substrate, cell
wall, or possibly both are changed in the daptomycin-resistant
strains. In order to investigate this further we prepared freeze-thaw
autolysin extracts from each strain and investigated their activities
on their own purified cell walls that do not retain autolytic activity
and on purified cell walls of the other strains. Freeze-thaw
autolysin extract from strain CB1118 caused good lysis of its own
purified cell walls (Figure 1c). However, freeze-thaw extracts of the
daptomycin-resistant strains had negligible activities on their own
purified cell walls (Figure 1c) or purified cell walls from strain
CB1118 (data not shown). Nevertheless, purified cell walls from
both strains 1540 and 1541 were readily digested by the freeze-
thaw extract from strain CB1118 (Figure 1d and e). This indicates
that the major reason for the decreased autolytic activity of strains
CB1540 and CB1541 is due to decreased autolysin activity rather
than a change in cell wall structure.
This was investigated further by zymographic determination of
the peptidoglycan hydrolase profiles of the strains (Figure 2). The
extract from strain CB1118 showed a typical peptidoglycan
hydrolase profile with multiple bands showing intense clearing of
the substrate in the gel [75,76]. In contrast, the freeze-thaw
extracts from the resistant strains were much less active when the
same amount of protein was loaded on the gels (Figure 2),
supporting the idea that there is less autolysin or less active
autolysin, assuming that the freeze-thaw extraction is equivalent in
all three strains.
The purified cell walls of strains CB1540 and CB1541 were less
susceptible to lysostaphin digestion than those of strain CB1118,
with strain CB1540 walls being the least susceptible (Figure 1f).
Because lysostaphin targets the glycylglycine interpeptide bridge
this may indicate some changes in the interpeptide bridge in the
mutants, which is compatible with changes in expression of fem
and femH genes that are involved in biosynthesis of the glycine
interpeptide bridge. Patel et al [24] reported decreased autolysis
and decreased lysostaphin susceptibility in some of the daptomy-
cin-resistant strains they studied. Their strains also had mutations
in walK, as did strains CB1540 and CB1541. Functional studies of
the same mutation in parent strain CB1118 would be necessary to
establish our walK mutation as contributing to decreased autolysis.
Bertsche et al. [77] compared the cell wall composition of
datomycin-resistant strains to susceptible parent strains. In the
resistant strains they found thicker cell walls, decreased peptido-
glycan O-acetylation, and increased amounts of total wall teichoic
acid that also showed increased D-alanylation. The decreased
autolytic activity of our daptomycin-resistant strains is very similar
to the situation described in VISA where decreased production or
activity of autolysin enzymes is responsible for decreased autolytic
activity [74]. The major autolysin of S. aureus is Atl [78] and we did
observe some decreased expression of atl in strain CB1541 (Table
S2). In contrast lytM was increased in expression 8 fold in strain
CB 1541 but the zymographic examination did not reflect
increased expression of LytM. However, the regulation of the
autolytic pathway is complex and involves proper localization of
autolysin in the cell wall and proteolytic processing of autolysins
[75,76,79], and further work will be necessary to understand the
autolysin deficiency in more detail.
Nevertheless, decreased autolysis is likely to increase the ability
of bacteria to survive the bactericidal effects of cell envelope-active
antibiotics like daptomycin and vancomycin [75,80] Since WalKR
plays an important role in autolysin regulation the mutation in
walK may well be involved in decreased autolysis [31], The agr-
negative phenotype of the strains may also be involved in
decreased autolysis [81].
Ultrastructure of the Strains
Strain CB1541 had walls that were about twice as thick as those
of the parent strain-48 nm versus 25 nm. Strain CB1540 walls
were slightly thicker than those of the parent strain (Figure 3).
Thickened cell wall is a common finding in daptomycin-resistant
strains [36] and it is thought that the thickened cell wall might
reduce the access of daptomycin to its target in the cytoplasmic
membrane. However, some daptomycin-resistant strains do not
show thicker cell walls [36]. In addition, misplaced division septa
were seen in strain CB1541, the strain with the thickest cell walls
(Figure 3). Shoji et al. [39] have reported that mutations in both
walK and clpP lead to thickened cell walls. Both strains CB1540
and CB1541 had a mutation in walK and strain CB1541 also had a
mutation in clpP.
Carotenoid Content And Fatty Acid Composition of
Daptomycin-Resistant Strains
The total carotenoid content of the strains was measured as
OD465 of warm methanol extracts [82,83] (Table 1) and indicated
that strains CB1540 and CB1541 had lower cell carotenoid
contents than the parent strain. Decreased carotenoid content is
consistent with the white color of CB1540 and CB1541 colonies.
Jones et al. [22] have provided evidence that increased
membrane fluidity is associated with daptomycin resistance. The
major determinant of membrane fluidity is the fatty acid
composition of the phospho- and glyco- glycerol membrane lipids
[84]. The fatty acid compositions of the strains are shown in Table
S1. The fatty acid composition of strain CB1541 was consistent
with increased membrane fluidity compared to that of parent
strain CB1118. Straight chain fatty acids were decreased to 20.7%
from 27.8%, iso fatty acids to 15.5% from 19.2% and anteiso fatty
acids increased to 63.9% from 52.6%. The anteiso:iso fatty acid
ratio was 4.1 in strain CB1541 compared to 2.7 in CB1118. Both a
decrease in carotenoid content and an increase in anteiso fatty
acids, are expected to result in increased membrane fluidity
[84,85], and this is in line with previous reports of an association
between decreased susceptibility to daptomycin and higher
membrane fluidity [22,29]. The fluorescence depolarization values
for the strains were: CB1118, 0.3160.02; CB1540, 0.3260.015;
CB1541, 0.2860.005, indicating that the membrane of strain
CB1541 is more fluid than those of the other two strains. The fatty
acid compositions of strains CB1540 and CB1118 were similar to
each other (Table S3).
Summation
Mutations in a considerable number of different genes have
been described in various laboratory and clinical daptomycin-
resistant strains. Mutations in phospholipid biosynthesis genes
have been commonly reported and these mutations may well alter
the interaction of daptomycin with its target, the membrane.
However, we did not observe any mutations in phospholipid
biosynthesis genes, although we did observe changes in fatty acid
composition and carotenoid content compatible with a more fluid
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Figure 1. Autolysis and lysostaphin susceptibility of strains CB1118, CB1540 and CB1541. (a), Triton X-100 stimulated whole cell
autolysis; (b), autolysis of isolated crude cell walls; (c), activity of autolysin extracts on purified cell walls (PCW); (d) and (e) activity of autolysin extracts
on PCW of the strain that was source of the autolysin extract and activity of strain CB1118 autolysin extract on strain CB1541 and CB1540 PCW (f)
lysostaphin digestion of PCW.
doi:10.1371/journal.pone.0058469.g001
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membrane that has previously been reported to be associated with
daptomycin resistance. In clinical MRSA isolates, Mishra et al.
[86] have hypothesized that the course of development of
daptomycin resistance could be influenced by in vivo exposures
to endogenous host defense peptides. In our strains we observed
mutations in walK and agrA. Both these systems appear to be
involved in control of autolytic activity. The transcriptomes of the
two resistant strains were different from each other. The
transcriptomes indicated significant changes in metabolism and
changes in display of cell surface proteins. Both strains appeared to
be primed to respond to daptomycin stress, which likely causes the
accumulation of damaged proteins, in that genes involved in
accumulation of compatible solutes were upregulated in both
strains, and heat shock chaperones and proteases genes were
upregulated in one strain. Both strains had much less autolytic
activity in freeze-thaw extract than the parent strain. Decreased
autolysis has been associated with tolerance to the killing action of
bactericidal antibiotics. We think this is important along with the
slow growth of the mutants, which is also associated with
decreased antibiotic susceptibility. Mutations in WalKR indicate
walKR may be one of a limited number of genes key for the
development of daptomycin and vancomycin resistance, such that
mutations in phospholipid biosynthesis genes may be unnecessary
for resistance development.
Materials and Methods
Strains Studied and Growth Conditions
The strains studied are described in Table 1. The daptomycin-
resistant strains CB1540 and CB1541 were obtained by serial
Figure 2. Zymographic analysis of autolysins. The strains from
which the autolysin extract was prepared and amount of protein loaded
are indicated on the top of the gels. Molecular mass markers are
indicated in kilodaltons on the left side of the gel. a,b. Atl (62 kDa-
51 kDa) c. LytN (46 kDa) d,. LytM (36 kDa).
doi:10.1371/journal.pone.0058469.g002
Figure 3. Ultrastructure of strains CB1118, CB1540 and CB1541. Magnification 50,0006.
doi:10.1371/journal.pone.0058469.g003
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passage of strain CB1118 (MW2, community-associated MRSA,
kindly provided by B.N. Kreiswirth), in the laboratory with
increasing concentrations of daptomycin as described previously
[30]. The serial passage was set up as a series of MICs using 3
different high test concentrations (20, 24 and 32 ug/ml). In order
to detect incremental changes in DAP susceptibility, an extended
gradient was created by combining the three sets of two fold
dilutions. 104 colony forming units (CFUs) of exponentially
growing cells were used as inocula into the first day’s MIC plates.
After approximately 18 hours of growth at 37uC, the MIC was
determined as the highest concentration that permitted growth
and then diluted 1:1000 to inoculate the next day’s plates
containing the same extended DAP gradient. The process was
repeated for 20 days, giving rise to CB1540 and CB1541 (as
independently derived from CB1118). Stability of the mutants was
established by maintenance of daptomycin MIC after four days or
more of transfer on drug-free medium. Strains CB1540 and
CB1541 are independent day 23 isolates. The strains were grown
in 50 ml Mueller-Hinton broth (Difco) supplemented with CaCl2
(50 ug ml21) in a 250 ml Erlenmeyer flask at 37uC with shaking at
210 rpm. Cultures were inoculated with 0.5 ml of an overnight
culture. For transcriptional profiling the strains were grown to an
OD600 nm of 0.4.
Transmission Electron Microscopy
Preparation and examination of S. aureus cells by transmission
electron microscopy were performed as described previously [87].
Thin sections stained with uranyl acetate and lead citrate were
examined in a Zeiss 10-C transmission electron microscope
operating at 60 kV. Cell-wall thickness measurements were
performed using photographic images at 50,0006 final magnifi-
cation. Thirty five cells of each strain with nearly equatorial cut
surfaces were measured, and results were expressed as mean value
6 standard deviation.
Complete-Genome Comparisons (CGS)
These were performed with an array-based service (CGS)
provided by Nimblegen Systems Inc (Madision, WI) [30,88]. The
reference genome was S. aureus MW2 (CB1118), which was
compared to those to those of strains CB1540 and CB1541.
PCR Amplification and DNA Sequencing
CGS-identified single nucleotide changes were confirmed by
sequencing of PCR-amplified regions covering each putative
nucleotide mutation. The PCR primers used are shown in Table 3.
Transcriptional Profiling
This was carried out essentially as described by Muthaiyan et al.
[11]. Total bacterial RNA was obtained using RNA protect
solution and breaking cells using the FastPrep system. Purified
labeled cDNA was hybridized with S. aureus genome microarrays
version 6.0 provided by the Pathogen Functional Genomics
Resource Center (PFGRC) of the National Institutes of Allergy
and Infectious Diseases (NIAID). The full genome array consists of
16024 70-mer oligonucleotides representing 4546 ORFs from S.
aureus strain COL, MW2, MSSA476, Mu50, MRSA252,
MSSA476, N315, USA300-FPR3757,and pLW043. Each ORF
is printed in four times on the array. Hybridization signals were
scanned, analyzed using TIGR spotfinder, normalized applying
the LOWESS algorithm using TIGR, MIDAS software. The
normalized log2 ratio of test to reference signal for each spot was
recorded. Genes with fewer than three data points were
considered unreliable, and their data points were discarded. The
averaged log2 ratio for each remaining gene on the six replicate
slides was ultimately calculated. Significant changes in gene
expression were identified with SAM (significance analysis of
microarrays; http://www-stat.stanford.edu/,tibs/SAM/) soft-
ware using one class mode. SAM assigns a score to each gene
on the basis of change in gene expression relative to the standard
deviation of repeated measurements. For genes with scores greater
than an adjustable threshold, SAM uses permutations of the
repeated measurements to estimate the percentage of genes
identified by chance, i.e., the false discovery rate. A cutoff of 2-
fold for over- and underexpressed ORFs was used. To examine
how genes with transcript level changes are distributed with regard
to their function, we further classified these genes using our in-
house software Gene Sorter according to the categories described
in the comprehensive microbial resource of TIGR (http://cmr.
tigr.org/tigr-scripts/CMR/shared/Genomes.cgi). Several controls
were employed to minimize the technical and biological variations
and to ensure that the data obtained were of good quality. First,
each ORF was present in triplicate on the array. Second, each
RNA preparation was used to make probes for at least two
separate arrays for which the incorporated dye was reversed.
Finally, three independent cultures were used to prepare RNA
samples.
Microarray Data Accession Number
The data discussed in this publication have been deposited in
NCBI’s Gene Expression Omnibus (GEO) (http://www.ncbi.nlm.
nih. gov/geo/) and are accessible through GEO Series accession
number GSE40753.
Microarray Validation By Real-Time Reverse
Transcription-PCR (RT-PCR)
To confirm the validity of microarray data, gene specific
mRNAs were quantified from resistant strains and parent strains
by quantitative real-time PCR. Total RNA preparation was
performed exactly as described for the microarray assay. Residual
DNA was removed from the samples by performing on-column
Table 3. PCR primers.
Genes Primers 59-39
walK Forward: ACTTTGGCGATGTACGTACG
Reverse: AGCCCGATAATTTGCATACC
prs Forward: TAAACGTCGTCCTAGACCAAATG
Reverse: TGCTTGTGCAGCTAAAGTGA
MW1109 Forward: GGATTTTGTAAAAATATTGAAAGTGAA
Reverse: CCTTTACCGCCACTATCAACA
pnpA Forward: AAGAAATCGTCAATGAATTTATCGA
Reverse: CAATTTCACGACGACCTGG
agrA Forward: ACTGATAATCCTTATGAGGTGC
Reverse: AAATAAAATCCATCGCTGCAA
MW1927 Forward: TGTTGCGATACTTGCGAATC
Reverse: ATTCGTCGATGAGCATTTCA
clpP Forward: CAAGCGCAAGACTCAGAGAA
Reverse: TGCAGCAATTTCGATTTCAG
MW1913 Forward: CTATCATTTCACGTATTTCTTTCC
Reverse: AACAAGAGGAGGAGATTTAAATGATG
doi:10.1371/journal.pone.0058469.t003
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DNase digestion step with RNase-free DNase (QIAGEN). cDNA
was synthesized using high capacity RNA-to-cDNA kit (Applied
Biosystems, Foster City, CA). Specific primers for the genes tested
and for 16S rRNA, were designed using Primer Express software
(Applied Biosystems) in order to design 100- to 200-bp amplicons
(Table 4). Real-time PCR was performed with the ABI PRISM
7300 sequence detection system (Applied Biosystems) and SYBR
green technology. Quantitative real-time PCRs (qRT-PCRs) were
performed in a 25-ml reaction volume containing 1 ml of a 1/100
dilution of cDNA, 1 ml of gene-specific primers (10 mM), and
12.5 ml of Power SYBR Green PCR Master Mix (Applied
Biosystems, Foster, CA). The expression levels of the tested genes
were normalized using the 16S rRNA gene of S. aureus as an
internal standard whose transcript level did not vary under our
experimental conditions. Each assay was performed in triplicate
and repeated with at least three independent RNA samples. No-
template reactions were included as negative controls. A negative
control without reverse transcriptase in the reaction was
performed to exclude the possibility of DNA contamination. All
samples were amplified in triplicate and the data analysis was
carried out using 7300 System software (Applied Biosystems).
Autolysis, Preparation of Cell Walls And Peptidoglycan
Hydrolase Profiles
Triton X-100 stimulated autolysis of whole-cells grown in MHB
was determined as described by Gustafson et al. [89]. Crude cell
walls retaining autolytic activity and purified cell walls, which have
been digested with trypsin and do not retain autolytic activity,
were prepared as described previously [75,90]. Freeze-thaw
autolysin and determination of peptidoglycan hydrolase profiles
by zymography were carried out as described by Koehl et al. [75].
Fatty Acid Composition
Washed exponential phase cells were saponified and methylated
and analyzed for fatty acid composition on an Agilent 5890 dual-
tower gas chromatograph. Fatty acids were identified using the
MIDI microbial identification system (Sherlock 4.5 Microbial
identification system) at Microbial ID (New York, DE) [91].
Total Carotenoid Determination
This was determined by extracting cells with warm methanol by
the method of Morikawa et al. [82] as described by Davis et al.
[83].
Measurement of Membrane Fluidity
This was determined as described previously [92]. In brief, mid
exponential phase cells (OD600 0.6) were washed twice with 0.85%
NaCl. Then cells were resuspended in 0.85% NaCl containing
2 uM 1,6-diphenyl-1, 3, 5-hexatriene (DPH; Sigma, MO) to an
OD600 of 0.3 and incubated at 30uC for 1 h. 1 mM DPH solution
was prepared in tetrahydrofuran, and 200 ml was added to 50 ml
of 0.85% NaCl. DPH fluoresces in the hydrophobic regions of the
lipid bilayer but does not fluoresce in an aqueous environment
[93]. Excess tetrahydrofuran was removed by flushing with
nitrogen. Fluorescence polarization was measured using Quanta-
MasterTM40 spectrofluorometer (Photon Technology Internation-
al, Inc., NJ). The excitation and emission wavelength for DPH
were 360 and 426 nm respectively. The higher the value is the
lower the membrane fluidity. The experiment was performed
twice, and the mean polarization values were compared for
significant differences by using the t test.
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Table 4. Primers for RT-PCR.
Genes primers 59-39
16s Forward CCACGCCGTAAACGATGAGT
Reverse CACATGCTCCACCGCTTGT
bet Forward GTTAAAACGAGGGCCAGCAA
Reverse ATTCGGCGACCACGATGTAC
gbsA Forward GGGTTGAAAGCGCGAATAAA
Reverse CTTGCGACCATTCACCAGACT
mscL Forward GGGTGCAGCTTTCAACAAGATT
Reverse AAGTCGATAACAGATTGGATAAATAAACC
ftsH Forward TCCTCCGCCAAGCACAAGGT
Reverse TGCAACCGCTCTAGCAAGTA
yycG Forward CAATCACCGATATGCGTAACCA
Reverse CAGTATTAGCCTGCGCTTCTTG
lytM Forward AGGTCCAGACGCGAGCTATTAT
Reverse TCTTTCGCATGACCACTAGCTG
lrgA Forward TCATTTATGCCAATTCCTATGCCT
Reverse ACCGGCTGGTACGAAGAGTAAG
lrgB Forward TTGGCATCGTATCATCGGAG
Reverse GATACTGGTAACGCAATCGCTG
accA Forward TCGCTTCGGGTGTTGATATT
Reverse TTACGCCTGCTTCAACCTTT
ftsA Forward TCGCTTCGGGTGTTGATATT
Reverse TTACGCCTGCTTCAACCTTT
doi:10.1371/journal.pone.0058469.t004
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